Cargando…
Novel Hydrogenated Derivatives of Chemically Modified Curcumin CMC2.24 Are Potent Inhibitors of Melanogenesis in an In Vitro Model: Influence of Degree of Hydrogenation
Chemically modified curcumin, CMC2.24, is a promising therapeutic that has shown efficacy in ameliorating excessive pigmentation in our previous studies. However, its inherent disadvantages of color, stability, solubility, and cytotoxicity to melanocytes and keratinocytes at concentrations > 4 µg...
Autor principal: | Goenka, Shilpi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304319/ https://www.ncbi.nlm.nih.gov/pubmed/37374155 http://dx.doi.org/10.3390/life13061373 |
Ejemplares similares
-
Novel Chemically Modified Curcumin (CMC) Analogs Exhibit Anti-Melanogenic Activity in Primary Human Melanocytes
por: Goenka, Shilpi, et al.
Publicado: (2021) -
Novel Chemically Modified Curcumin (CMC) Derivatives Inhibit Tyrosinase Activity and Melanin Synthesis in B16F10 Mouse Melanoma Cells
por: Goenka, Shilpi, et al.
Publicado: (2021) -
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs
por: Deng, Jie, et al.
Publicado: (2020) -
A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization
por: Deng, Jie, et al.
Publicado: (2023) -
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss
por: Bhatt, Heta Dinesh, et al.
Publicado: (2023)